S
VIVO

SignatureFD’s Meridian Bioscience Inc VIVO Stock Holding History

SignatureFD’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20
Closed -$664 – 3437
2022
Q4 		$664 Sell
20
-29
-59% -$934 ﹤0.01% 3058
2022
Q3 		$2K Sell
49
-6
-11% -$194 ﹤0.01% 2884
2022
Q2 		$2K Sell
55
-18
-25% -$487 ﹤0.01% 2847
2022
Q1 		$2K Sell
73
-23
-24% -$547 ﹤0.01% 2906
2021
Q4 		$2K Buy
96
+75
+357% +$1.44K ﹤0.01% 2836
2021
Q3 		$0 Buy
+21
New +$419 ﹤0.01% 3276
2021
Q2 		– Sell
-118
Closed -$3K – 3114
2021
Q1 		$3K Hold
118
– – ﹤0.01% 2413
2020
Q4 		$2K Hold
118
– – ﹤0.01% 2347
2020
Q3 		$2K Hold
118
– – ﹤0.01% 2320
2020
Q2 		$3K Buy
+118
New +$1.71K ﹤0.01% 2050
2020
Q1 		– Sell
-107
Closed -$1K – 2524
2019
Q4 		$1K Buy
+107
New +$1K ﹤0.01% 2148

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SignatureFD's VIVO Position: Q1 2023 in Review

SignatureFD sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 20 shares — an estimated $664 sold.

SignatureFD first reported a position in VIVO in Q4 2019 and held it in 11 quarters. The position peaked at $3K in Q1 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • SignatureFD reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • SignatureFD sold 20 Meridian Bioscience Inc shares in Q1 2023, an estimated $664.
  • SignatureFD first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 11 quarters.
  • SignatureFD's Meridian Bioscience Inc position peaked at $3K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on SignatureFD's 13F filing for Q1 2023, filed 28 Apr 2023.